Taiwan FDA registration cc6c8dc76813ec5576e194e786feede3
"Abbott" glucose test set
TW: “亞培” 葡萄糖檢驗試劑組
Taiwan·Risk Class 2·ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.·Registered Feb 21, 2019 – Feb 21, 2029ActiveRegistration details
- Analysis ID
- cc6c8dc76813ec5576e194e786feede3
- Customs Code
- DHA05603218302
Company information
- Manufacturer
- ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.
- Manufacturer Country
- Canada;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product can be used to quantitatively determine glucose in human serum, plasma, urine or cerebrospinal cord (CSF) on the Alinity c analyzer.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Feb 21, 2019
- Expiry Date
- Feb 21, 2029
About this record
Access comprehensive regulatory information for "Abbott" glucose test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cc6c8dc76813ec5576e194e786feede3 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices